Skip to content

Category: University of RochesterSyndicate content

Volatile gas could turn Rwandan lake into a freshwater time bomb

November 16, 2009

A dangerous level of carbon dioxide and methane gas haunts Lake Kivu, the freshwater lake system bordering Rwanda and the Republic of Congo.

Pilot study relates phthalate exposure to less-masculine play by boys

November 16, 2009

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.

The University of Rochester Medical Center-led study is published in the International Journal of Andrology.

Squeak, squeak -- can you hear me now?

November 9, 2009

What do you get when you cross a mouse with poor hearing and a mouse with even worse hearing?

Study uses satellite imagery to identify active magma systems in East Africa's Rift Valley

November 4, 2009

A team from the University of Miami, University of El Paso and University of Rochester have employed Interferometric Synthetic Aperture Radar (InSAR) images compiled over a decade to study volcanic ac

Common pain relievers may dilute power of flu shots

November 3, 2009

With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers -- Advil, Tylenol, aspirin -- at the time of inje

African desert rift confirmed as new ocean in the making

November 2, 2009

In 2005, a gigantic, 35-mile-long rift broke open the desert ground in Ethiopia.

Powerful laser sheds light on fast ignition and high energy density physics

November 2, 2009

A new generation of high-energy (>kJ) petawatt (HEPW) lasers is being constructed worldwide to study high intensity laser matter interactions, including fast ignition.

Cost effectiveness of blood pressure device evaluated

October 15, 2009

A study conducted by the University of Rochester Medical Center demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug resistant hypertension.

Rochester-led Parkinson's study pays off again, 2 decades later

October 12, 2009

Parkinson disease progresses more slowly in patients who have higher levels of urate, a chemical that at very high level is associated with gout, scientists have found.

Women with breast cancer have low vitamin D levels

October 8, 2009

Women with breast cancer should be given high doses of vitamin D because a majority of them are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures, according to scientists at the University of Rochester Medical Center.

Where surgery was the standard, casting may be the future

September 30, 2009

When parents are told their babies' scoliosis needs treatment, they often try bracing first. If that fails, they need surgery to place metal rods in their backs with spinal fusion later on. These children face the risk of complications from the surgery and their backs and chests may be stiff for life.

Young adults visit doctors least at an age when risky behavior peaks

September 25, 2009

When adolescents graduate to young adulthood, their preventive care tends to fall by the wayside. A recent study has found that young adults are much less likely to use ambulatory or preventive care, even though their mortality rate is more than twice that of adolescents.

Viagra relatives may shrink abnormally large hearts

September 24, 2009

Compounds related to Viagra, which is already in clinical trials to prevent heart failure, may also counter the disease in a different way, according to a study published online today in the journal Circulation Research. The results hold promise for the design of a new drug class and for its potential use in combination with Viagra or beta blockers.

Experimental approach may reverse rheumatoid arthritis and osteoporosis

September 21, 2009

Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online today in the Journal of Clinical Investigation.

Experimental drug lets B cells live and lymphoma cells die

September 21, 2009

An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.